Mirvi raises 60M for early preeclampsia detection and further digital development

Mirvi, who is developing a blood test aimed at identifying the risk of preeclampsia before symptoms appear, has raised $ 60 million in the Series B fund.

The round was led by Dechang Capital with participation from funds managed by Blackrock, Foresight Capital, General Catalyst, GV, Khosla Ventures, Mayfield and Olympic gold medalist Alison Felix. It also includes a loan facility with Comerica Bank.

Mirvie announced it was Earlier this month, it was designated a breakthrough device for preeclampsia testing. The startup is studying to predict premature births using its RNA platform.

Min Qui, founder and managing director of Decheng Capital, said in a statement, “Mirvi is a trailblazer in a case desperate to innovate in tackling the often devastating and costly lifetime consequences of pregnancy complications.” “This fund is committed to supporting Mirvi’s goal of providing syndicate physicians, expecting parents and children to make groundbreaking innovations that make the impossible a reality today.”

The nurse practitioner support platform has raised $ 10 million in a fundraising round led by Greater Good Health LRVHealth.

Other participants in the round include Martin Ventures, Health Velocity Capital and Optam Ventures, as well as angel investors. Greater Good’s platform includes tools for scheduling, professional development, wellness and stress management, and networking with other nurse practitioners. It is Launched from Stealth in December, and has now raised a total of 13 million.

The startup, which currently operates mainly in the West Coast, plans to use the investment to expand geographically and integrate services with value-based provider groups, hospitals and health plans.

“Nurses practitioners, along with other healthcare professionals, have been devalued and burned over the years – a feeling that was exacerbated by the epidemic and continues to be so,” said Greater Health. CEO and founder Sylvia Hastanan said in a statement. “As a result, the nation is facing an alarming shortage of healthcare workers, especially in primary care. To help address provider burnout, it is important to create and expand systems designed to help healthcare professionals work on top of their licenses.”

ThoroughCare, which offers ready-made care adjustment software toward value-based providers, has raised 3 million from Cypress Growth Capital.

The startup provides tools for chronic care management, remote patient monitoring, behavioral health, conducting annual wellness inspections, and tracking post-discharge care.

“This capital investment recognizes ThoroughCare’s mission and value proposition to help facilitate the integration of care and value-based care delivery through digital solutions,” said ThoroughCare CEO and founder Dan Godla said in a statement. “With this funding, we look forward to expanding our reach and providing software solutions that enhance clinical and operational efficiency for healthcare providers across the country.”

Leave a Reply

Your email address will not be published.